At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Controlled Trial of Autologous Microbiome Reconstitution to Prevent Colonization by Antibiotic rEsistant Bacteria
In Brief
A Phase 1 clinical trial evaluating Autologous fecal microbiota transplant (Auto-FMP Enema) and Placebo Enema Preparation for Antibiotic Resistant Strain. Completed, enrolled 7 participants across 1 site.
Detailed Summary
This study, a Randomized controlled trial of Autologous microbiome reconstitution to prevent Colonization by antibiotic rEsistant bacteria (RACE), seeks to investigate the safety, feasibility and the role of autologous fecal microbiota transplantation (FMT) for the prevention of antibiotic resistant bacteria (ARB) through microbiome restoration.
Study Details
Timeline
Interventions
FMT is the process by which processed donor microbiota material is transplanted into recipients. The aim is to reconstitute the normal intestinal microbial flora in recipients. In this study, the fecal microbiota preparation will be made from the participant's own stool and processed into an auto-FMP enema formulation.
The placebo enema preparation will be identical in appearance but will not contain human feces to prevent unmasking of the trial arms.